<DOC>
	<DOCNO>NCT02721173</DOCNO>
	<brief_summary>The combination therapy retinoid clindamycin acne preferred target multiple area acne pathogenesis could accomplish monotherapy , thereby improve outcome . Literature review reveals till date publish comparative study assess safety efficacy tazarotene plus clindamycin adapalene plus clindamycin . So present study design compare two combination therapy acne vulgaris .</brief_summary>
	<brief_title>Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin Treatment Facial Acne Vulgaris</brief_title>
	<detailed_description>Acne vulgaris one common disorder treated dermatologist . The pathogenesis acne multifactorial . Critical component include abnormal follicular keratinocyte desquamation lead formation follicular plug ( microcomedo ) , increase sebum production pilosebaceous unit , colonization Propionibacterium acne , inflammation . Topical retinoids , target comedogenesis anti-inflammatory activity , recommend first-line therapy inflammatory non-inflammatory acne . The adjunctive use anti-acne agent like clindamycin complementary mechanism action help enhance efficacy topical retinoid therapy still . Tazarotene synthetic retinoid prodrug convert skin active form , tazarotenic acid . The active form bind retinoic acid receptor ( RARs ) regulate gene transcription help normalize abnormal keratinization follicular infundibulum , turn change microenvironment follicle thereby reduce proliferation Propionibacterium acne . Adapalene synthetic naphthoic acid derivative retinoid activity . Adapalene also act RARs modulate cellular keratinization inflammatory process . Clindamycin bactericidal Propionibacterium acne . Due inhibition P. acne free fatty acid level pilosebaceous unit skin also reduce . Clindamycin phosphate apply topically penetrate great extent open comedo thus produce high percentage sterile comedo . The combination therapy retinoid clindamycin acne preferred target multiple area acne pathogenesis could accomplish monotherapy , thereby improve outcome . Literature review reveals till date publish comparative study assess safety efficacy tazarotene plus clindamycin adapalene plus clindamycin . So present study design compare two combination therapy acne vulgaris .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>All patient diagnosis facial acne vulgaris comedo , papule , pustule ( ≤5 ) , nodule ( ≤2 ) Investigator 's static global assessment score ≤4 Treatment naïve patient patient take topical antiacne medication last 14 day , systemic antibiotic last 30 day , oral retinoids last 12 month Very severe acne vulgaris ( Investigator 's static global assessment score &gt; 4 ) Any skin disorder might interfere diagnosis evaluation acne vulgaris Known hypersensitivity retinoids clindamycin Any uncontrolled systemic disease cosmetic surgical procedure complementary treatment acne precede 15 day Patients oral contraceptive pill last 12 week Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Tazarotene</keyword>
	<keyword>Adapalene</keyword>
	<keyword>Clindamycin</keyword>
</DOC>